Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.
about
Carrageenan is a potent inhibitor of papillomavirus infectionTwo highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytesCutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropismCurrent understanding of the mechanism of HPV infectionPapillomavirus Infectious Pathways: A Comparison of SystemsThe cytoskeleton in papillomavirus infectionConcepts of papillomavirus entry into host cellsDifferential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV typesPotential anti-HPV and related cancer agents from marine resources: an overview.Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.Cellular receptor binding and entry of human papillomavirus.Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation.Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types.Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections.Papillomavirus infection requires gamma secretase.Binding and neutralization characteristics of a panel of monoclonal antibodies to human papillomavirus 58.Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells.Replication and assembly of human papillomaviruses.Evaluation of pneumonia virus of mice as a possible human pathogenHuman papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytesInhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.Use of an in vivo animal model for assessing the role of integrin α(6)β(4) and syndecan-1 in early steps in papillomavirus infection.Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapiesCaveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating.Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.The papillomavirus major capsid protein L1.Identification of TRAPPC8 as a host factor required for human papillomavirus cell entryHuman papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs.The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis.Viral entry mechanisms: human papillomavirus and a long journey from extracellular matrix to the nucleus.Human Papillomavirus (HPV) virion induced cancer and subfertility, two sides of the same coin.HPV disease transmission protection and control.Principles of polyoma- and papillomavirus uncoating.Herpes Simplex Virus 1 Enters Human Keratinocytes by a Nectin-1-Dependent, Rapid Plasma Membrane Fusion Pathway That Functions at Low Temperature.Using organotypic (raft) epithelial tissue cultures for the biosynthesis and isolation of infectious human papillomaviruses.Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.Human papillomavirus and non-small cell lung cancer.The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.Superinfection Exclusion between Two High-Risk Human Papillomavirus (HPV) Types During a Co-Infection.
P2860
Q21089628-380E04DA-4659-400C-B32C-465CE446C383Q21143868-CF8C5A0C-E7DA-4C5F-B55D-333842E073A4Q21245129-703CB9F1-5D1C-4841-9185-14DFCA395377Q24616134-BBB11FFF-9AE6-4570-83F2-833556384605Q26801497-D8F5097F-95D8-45D1-B425-0CA30A569D4EQ26861667-4BB8A1AA-B7A1-4361-9181-174C9146E73AQ27026900-2FAB5B27-58A6-49A7-8E51-06ABAA67A9DAQ28534531-103775E8-1DAD-4C28-8C04-E9DCF2EA45A8Q33575647-9D89A4DE-F93F-4306-AC66-00EE00C35E65Q33591582-768CD28C-ABD2-4B26-915E-279B8979F4C2Q33647192-27B161F1-77AB-42F1-AAFA-9BC9B1B230FFQ33879132-BA1A19BD-1370-4A52-8E3E-B0DA11048949Q33923898-2E326C5C-71C2-4930-A0BF-3ACD0DD9779AQ34162277-5E7B6694-7591-4599-BBF9-4A79E5FB694BQ34178325-9E9F3E5B-1473-4833-B72D-BDCEFF282C64Q34641651-B74AC94A-2A33-4FE7-BA63-F778D650D525Q35024219-B82B1AEE-98F9-4B19-B0C1-A2000CFC3EBDQ35866498-0C0CCE39-6F71-4E20-A90F-5146FA0016F3Q35943578-E6979CE8-4285-473A-B01B-41A5BED05C51Q36098845-A08C0C15-C674-4C9F-9EE2-601FC8BDE655Q36099326-CE17365B-1F64-426F-A5FD-4A2E9D93EE85Q36303591-EB24AB46-7785-451C-AFC1-0335DF52E258Q36481634-DEE50966-CEDF-490A-B170-385E2D60A6E4Q36898793-1D8EE9C1-FC98-4767-B3F9-2FBB3F8C98F5Q37099713-3C6F3F37-C1A7-4E57-8BB9-3FE0BE49BE61Q37198519-2221CA7C-BE15-4E01-A656-59121ACD9ED0Q37308756-C79645B4-37EF-4D02-81BF-487B10A1394DQ37410680-10151717-EA8A-4BB3-883A-AEFDE68A122FQ37415380-77DFF9DD-1CAE-4BE8-92E1-EC00187A237FQ37480444-4D6E6E30-FEA2-414F-960E-0775A15766D0Q37637430-4116DD4E-A2BB-4F58-B337-C700AB99C33EQ37705703-88B47B0F-944E-42C6-A2F3-DAF6E329B059Q38045782-071929FA-0E2D-445C-B4E4-5842C6D32615Q38736090-E0CD85C4-38F2-4601-8CF8-88951B453470Q38969707-57B16420-7D82-49EA-B8DE-9E7AC3D5CCCAQ40166422-E3C4B571-5FEE-4B34-85CE-61BF055BCC22Q42258973-F1098D66-C518-4581-BFEA-E9740EFAD654Q47551866-9C43268F-8DD6-4705-98D6-BA64B4ECE4BDQ50043357-D9C8BDB5-BF7E-417A-B3DA-8B2298F3B71E
P2860
Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Human papillomavirus type 31b ...... s not require heparan sulfate.
@en
type
label
Human papillomavirus type 31b ...... s not require heparan sulfate.
@en
prefLabel
Human papillomavirus type 31b ...... s not require heparan sulfate.
@en
P2093
P2860
P1433
P1476
Human papillomavirus type 31b ...... s not require heparan sulfate.
@en
P2093
Jessica L Smith
Michelle A Ozbun
Nicole A Patterson
P2860
P304
P356
10.1128/JVI.79.11.6838-6847.2005
P407
P577
2005-06-01T00:00:00Z